Millar EK - Search Results

1

Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.

Beretov J, Wasinger VC, Millar EK, Schwartz P, Graham PH, Li Y. Beretov J, et al. Among authors: millar ek. PLoS One. 2015 Nov 6;10(11):e0141876. doi: 10.1371/journal.pone.0141876. eCollection 2015. PLoS One. 2015. PMID: 26544852 Free PMC article.

2

Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.

Millar EK, Beretov J, Marr P, Sarris M, Clarke RA, Kearsley JH, Lee CS. Millar EK, et al. Histopathology. 1999 Jun;34(6):491-6. doi: 10.1111/j.1365-2559.1999.00666.x. Histopathology. 1999. PMID: 10383692

3

Mucinous differentiation in colonic adenocarcinoma is associated with a reduction in tumour-infiltrating lymphocytes.

Millar EK, Beretov J, Sarris M, Lee CS. Millar EK, et al. Eur J Surg Oncol. 2001 Apr;27(3):273-7. doi: 10.1053/ejso.2000.1094. Eur J Surg Oncol. 2001. PMID: 11373104

4

Supraclavicular radiotherapy must be limited laterally by the coracoid to avoid significant adjuvant breast nodal radiotherapy lymphoedema risk.

Graham P, Jagavkar R, Browne L, Millar E. Graham P, et al. Australas Radiol. 2006 Dec;50(6):578-82. doi: 10.1111/j.1440-1673.2006.01658.x. Australas Radiol. 2006. PMID: 17107530

5

p27KIP-1, cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27KIP-1 correlates with hormone receptor status but not with local recurrence.

Millar EK, Tran K, Marr P, Graham PH. Millar EK, et al. Pathol Int. 2007 Apr;57(4):183-9. doi: 10.1111/j.1440-1827.2007.02079.x. Pathol Int. 2007. PMID: 17316413

6

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.

Millar EK, Graham PH, O'Toole SA, McNeil CM, Browne L, Morey AL, Eggleton S, Beretov J, Theocharous C, Capp A, Nasser E, Kearsley JH, Delaney G, Papadatos G, Fox C, Sutherland RL. Millar EK, et al. J Clin Oncol. 2009 Oct 1;27(28):4701-8. doi: 10.1200/JCO.2008.21.7075. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720911 Clinical Trial.

7

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.

Millar EK, Graham PH, McNeil CM, Browne L, O'Toole SA, Boulghourjian A, Kearsley JH, Papadatos G, Delaney G, Fox C, Nasser E, Capp A, Sutherland RL. Millar EK, et al. Br J Cancer. 2011 Jul 12;105(2):272-80. doi: 10.1038/bjc.2011.228. Epub 2011 Jun 28. Br J Cancer. 2011. PMID: 21712826 Free PMC article.

8

The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial.

Hau E, Browne L, Capp A, Delaney GP, Fox C, Kearsley JH, Millar E, Nasser EH, Papadatos G, Graham PH. Hau E, et al. Breast Cancer Res Treat. 2013 May;139(1):115-23. doi: 10.1007/s10549-013-2508-z. Epub 2013 Apr 12. Breast Cancer Res Treat. 2013. PMID: 23580069 Clinical Trial.

9

Proteomics for breast cancer urine biomarkers.

Beretov J, Wasinger VC, Graham PH, Millar EK, Kearsley JH, Li Y. Beretov J, et al. Among authors: millar ek. Adv Clin Chem. 2014;63:123-67. doi: 10.1016/b978-0-12-800094-6.00004-2. Adv Clin Chem. 2014. PMID: 24783353 Review.

10

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.

Stone A, Zotenko E, Locke WJ, Korbie D, Millar EK, Pidsley R, Stirzaker C, Graham P, Trau M, Musgrove EA, Nicholson RI, Gee JM, Clark SJ. Stone A, et al. Among authors: millar ek. Nat Commun. 2015 Jul 14;6:7758. doi: 10.1038/ncomms8758. Nat Commun. 2015. PMID: 26169690 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page